| Literature DB >> 15509181 |
Xihong Wang1, Kenneth F Bastow, Chang-Ming Sun, Yun-Lian Lin, Hsi-Jung Yu, Ming-Jaw Don, Tian-Shung Wu, Seikou Nakamura, Kuo-Hsiung Lee.
Abstract
Neo-tanshinlactone (1) was isolated and synthesized for the first time and evaluated in vitro against several human cancer cell lines. Compound 1 showed significant inhibition against two ER+ human breast cancer cell lines and was 10-fold more potent and 20-fold more selective as compared to tamoxifen citrate. Compound 1 also potently inhibited an ER-, HER-2 overexpressing breast cancer cell line. Therefore, this novel compound merits further development as an anti-breast cancer drug candidate.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15509181 DOI: 10.1021/jm040112r
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446